Replay: Replay wins IND clearance for PRAME T cell cancer therapy

The US-based company is working alongside the University of Texas MD Anderson Cancer Center to fund the Phase I/II clinical trial.The post Replay wins IND clearance for PRAME T cell cancer therapy appeared first on Clinical Trials Arena.